Our first child in the spotlight was Addison Zearfaus, daughter of Mark and Jessica Zearfaus. Addison was diagnosed with ALL in May 2016 at the age of 7. Her birthday is January 26th. The Brian Morden Foundation donated $1000 to the Leukemia and Lymphoma Society in her honor.
For more information about Addison, click here.
For more information about the BMF CARES Spotlight or to donate to the Brian Morden Foundation, please contact Dawn Morden, president of the BMF at firstname.lastname@example.org. Contributions may also be made here or at the Central Pennsylvania Community Foundation.
Important additional Information in the Spotlight:
February 2018 - Non-Hodgkins Lymphoma
Non-Hodgkin's lymphoma is cancer that originates in your lymphatic system, the disease-fighting network spread throughout your body. In non-Hodgkin's lymphoma, tumors develop from lymphocytes — a type of white blood cell.
For more, see information from the Mayo Clinic.
January 2018 - Leukemia
The most common type of childhood cancer is leukemia, a cancer of the blood. Leukemia begins in the bone marrow, the spongy substance inside our bones where blood cells are made.
Other childhood cancers include lymphoma (blood cancer that begins in the lymph glands) and solid tumors (abnormal clumps of tissue). Solid tumors may occur throughout the body, such as in the brain, kidney, muscle or bone.
The causes of childhood cancer are largely unknown. Childhood cancer can occur suddenly, with no early symptoms, and might get detected during a physical exam.
“If you notice something unusual in your child—unexplained symptoms, not growing properly, belly distended, blood in urine—take your child to the doctor,” says Dr. Nita Seibel, a pediatric oncologist at NIH. If the doctor suspects cancer, a series of tests will help identify the type of cancer, where it’s located and whether it has spread to other parts of the body.
Cancers in children can be different from adult cancers. When you’re researching the diagnosis, be sure you’re looking at how that cancer affects children. Often, the outcomes may be better for children than for adults with the same type of cancer.
For instance, Seibel says, childhood tumors tend to respond better to treatment than do tumors in adults. Cancer cells tend to grow very swiftly in the types of tumors seen in children. So therapies can be selected to interrupt this rapid growth.
Children with leukemia, non-Hodgkin’s lymphoma or certain solid tumors tend to have a good outcome.
For more information about leukemia, see https://www.cancer.gov/types/leukemia or Leukemia and Lymphoma Society.